A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Coignard, J; Lush, M; Beesley, J; O'Mara, TAORCID logo; Dennis, JORCID logo; Tyrer, JPORCID logo; Barnes, DRORCID logo; McGuffog, L; Leslie, GORCID logo; Bolla, MK; +214 more...Adank, MA; Agata, S; Ahearn, TORCID logo; Aittomäki, K; Andrulis, ILORCID logo; Anton-Culver, H; Arndt, VORCID logo; Arnold, N; Aronson, KJ; Arun, BK; Augustinsson, A; Azzollini, JORCID logo; Barrowdale, DORCID logo; Baynes, C; Becher, HORCID logo; Bermisheva, M; Bernstein, LORCID logo; Białkowska, K; Blomqvist, C; Bojesen, SEORCID logo; Bonanni, BORCID logo; Borg, A; Brauch, HORCID logo; Brenner, H; Burwinkel, B; Buys, SS; Caldés, TORCID logo; Caligo, MA; Campa, D; Carter, BD; Castelao, JE; Chang-Claude, J; Chanock, SJORCID logo; Chung, WKORCID logo; Claes, KBORCID logo; Clarke, CL; GEMO Study Collaborators; EMBRACE Collaborators; Collée, JMORCID logo; Conroy, DM; Czene, K; Daly, MB; Devilee, PORCID logo; Diez, O; Ding, YC; Domchek, SM; Dörk, TORCID logo; Dos-Santos-Silva, IORCID logo; Dunning, AMORCID logo; Dwek, MORCID logo; Eccles, DM; Eliassen, AHORCID logo; Engel, C; Eriksson, M; Evans, DG; Fasching, PA; Flyger, H; Fostira, F; Friedman, E; Fritschi, LORCID logo; Frost, D; Gago-Dominguez, M; Gapstur, SM; Garber, J; Garcia-Barberan, V; García-Closas, MORCID logo; García-Sáenz, JAORCID logo; Gaudet, MM; Gayther, SAORCID logo; Gehrig, A; Georgoulias, V; Giles, GGORCID logo; Godwin, AK; Goldberg, MS; Goldgar, DE; González-Neira, A; Greene, MHORCID logo; Guénel, PORCID logo; Haeberle, L; Hahnen, E; Haiman, CA; Håkansson, NORCID logo; Hall, P; Hamann, U; Harrington, PA; Hart, SNORCID logo; He, WORCID logo; Hogervorst, FB; Hollestelle, AORCID logo; Hopper, JL; Horcasitas, DJ; Hulick, PJORCID logo; Hunter, DJ; Imyanitov, EN; KConFab Investigators; HEBON Investigators; ABCTB Investigators; Jager, A; Jakubowska, AORCID logo; James, PAORCID logo; Jensen, UBORCID logo; John, EM; Jones, MEORCID logo; Kaaks, R; Kapoor, PMORCID logo; Karlan, BY; Keeman, RORCID logo; Khusnutdinova, E; Kiiski, JI; Ko, Y; Kosma, V; Kraft, PORCID logo; Kurian, AWORCID logo; Laitman, Y; Lambrechts, DORCID logo; Le Marchand, L; Lester, J; Lesueur, FORCID logo; Lindstrom, T; Lopez-Fernández, A; Loud, JT; Luccarini, C; Mannermaa, A; Manoukian, S; Margolin, S; Martens, JWORCID logo; Mebirouk, N; Meindl, A; Miller, AORCID logo; Milne, RLORCID logo; Montagna, M; Nathanson, KLORCID logo; Neuhausen, SL; Nevanlinna, HORCID logo; Nielsen, FC; O'Brien, KM; Olopade, OIORCID logo; Olson, JEORCID logo; Olsson, H; Osorio, A; Ottini, LORCID logo; Park-Simon, T; Parsons, MTORCID logo; Pedersen, ISORCID logo; Peshkin, BORCID logo; Peterlongo, PORCID logo; Peto, JORCID logo; Pharoah, PDORCID logo; Phillips, K; Polley, EC; Poppe, B; Presneau, N; Pujana, MA; Punie, KORCID logo; Radice, PORCID logo; Rantala, J; Rashid, MU; Rennert, GORCID logo; Rennert, HS; Robson, MORCID logo; Romero, AORCID logo; Rossing, M; Saloustros, EORCID logo; Sandler, DPORCID logo; Santella, R; Scheuner, MT; Schmidt, MKORCID logo; Schmidt, G; Scott, CORCID logo; Sharma, P; Soucy, P; Southey, MC; Spinelli, JJ; Steinsnyder, Z; Stone, JORCID logo; Stoppa-Lyonnet, D; Swerdlow, A; Tamimi, RM; Tapper, WJ; Taylor, JA; Terry, MB; Teulé, A; Thull, DL; Tischkowitz, M; Toland, AEORCID logo; Torres, D; Trainer, AH; Truong, TORCID logo; Tung, N; Vachon, CMORCID logo; Vega, AORCID logo; Vijai, JORCID logo; Wang, Q; Wappenschmidt, B; Weinberg, CR; Weitzel, JNORCID logo; Wendt, C; Wolk, AORCID logo; Yadav, SORCID logo; Yang, XR; Yannoukakos, DORCID logo; Zheng, W; Ziogas, AORCID logo; Zorn, KKORCID logo; Park, SKORCID logo; Thomassen, M; Offit, K; Schmutzler, RK; Couch, FJ; Simard, JORCID logo; Chenevix-Trench, G; Easton, DFORCID logo; Andrieu, N; Antoniou, AC and (2021) A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature communications, 12 (1). 1078-. ISSN 2041-1723 DOI: 10.1038/s41467-020-20496-3
Copy

Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.


picture_as_pdf
s41467-020-20496-3.pdf
subject
Published Version
Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads